Volume 31, Issue 145 (March & April 2023)                   J Adv Med Biomed Res 2023, 31(145): 197-203 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Asadi R, Raouf Sarshoori J, Ghorbani M, Mofid M. Evaluation of the Effect of Boron on Histopathological Changes of Atherosclerotic Plaque in Aortic Arch and Lipid Profiles in Hyperlipidemic New Zealand Male Rabbits. J Adv Med Biomed Res 2023; 31 (145) :197-203
URL: http://journal.zums.ac.ir/article-1-6836-en.html
1- Dept. of Anatomy, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran
2- Dept. of Anatomy, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran , raoufsar@gmail.com
3- Dept. of Pharmacology and Toxicology, Faculty of Pharmacy, Baqiyatallah University of Medical Sciences, Tehran, Iran
Abstract:   (10990 Views)

Background and Objective: Cardiovascular diseases are the most important causes of death worldwide. Atherosclerosis, as a common form of cardiovascular disease, tends to involve specific areas of the circulatory system. Boron has anti-inflammatory and antioxidant properties with potential beneficial effects. In this study, we investigated the effect of Boron on histopathological changes of atherosclerotic plaque and lipid profile in hyperlipidemic rabbits.
Materials and Methods: Male rabbits in five groups of control, sham, hyperlipidemia, treatment 1 and treatment 2 were fed on high fat diet (1% cholesterol). Treatment groups received Boron, 4 mg / kg, on the first and 20th days of experiment. Animals’ weights were measured on days 1, 21 and 60. Plasma levels of Cholesterol, LDL, HDL and TG were measured by photometric method. After 60 days, Sudan IV staining method was used for macroscopic study. Hematoxylin-eosin and Masson’s trichrome staining method were performed for quantitative analysis.
Results: Animals in the control and sham groups showed no significant change in serum lipid profile with no atherosclerotic plaque in aortic vessels. In the hyperlipidemia group, significant alterations in lipid profile and presence of atheroma plaques were detected. In animals receiving Boron as a protective agent, atheroma plaques were significantly less (p <0.05). This was confirmed by quantitative analysis.
Conclusion: Boron ameliorates the development and progression of atherosclerotic plaques. Boron can be used alone or in combination with other drugs as anti-atherosclerotic treatment.

Full-Text [PDF 623 kb]   (7862 Downloads) |   |   Full-Text (HTML)  (781 Views)  

Boron ameliorates the development and progression of atherosclerotic plaques. Boron can be used alone or in combination with other drugs as anti-atherosclerotic treatment.


Type of Study: Original Article | Subject: Pharmacology
Received: 2022/01/12 | Accepted: 2022/08/20 | Published: 2023/03/13

References
1. Bruikman CS, Stoekenbroek RM, Hovingh GK, Kastelein JP. New drugs for atherosclerosis. Canad J Cardiol. 2017;33(3):350-7. [DOI:10.1016/j.cjca.2016.09.010] [PMID]
2. Zengin E, Bickel C, Schnabel RB, et al. Risk factors of coronary artery disease in secondary prevention-results from the atherogene study. PLOS ONE. 2015;10(7):e0131434. [DOI:10.1371/journal.pone.0131434] [PMID] [PMCID]
3. Santos JCd, Cruz MS, Bortolin RH, et al. Relationship between circulating VCAM-1, ICAM-1, E-selectin and MMP9 and the extent of coronary lesions. Clinics. 2018;73. [DOI:10.6061/clinics/2018/e203] [PMID] [PMCID]
4. Fatkhullina AR, Peshkova IO, Koltsova EK. The role of cytokines in the development of atherosclerosis. Biochemistry (Mosc). 2016;81(11):1358-70. [DOI:10.1134/S0006297916110134] [PMID] [PMCID]
5. Momiyama Y, Adachi H, Fairweather D, Ishizaka N, Saita E. Inflammation, atherosclerosis and coronary artery disease. Clin Med Insights Cardiol. 2016;8(Suppl 3):67-70. [DOI:10.4137/CMC.S39423] [PMID] [PMCID]
6. Spagnoli LG, Bonanno E, Sangiorgi G, Mauriello A. Role of inflammation in atherosclerosis. J Nuclear Med. 2007;48(11):1800-15. [DOI:10.2967/jnumed.107.038661] [PMID]
7. Bittencourt MS, Cerci RJ. Statin effects on atherosclerotic plaques: regression or healing? BMC Med. 2015;13:260-. [DOI:10.1186/s12916-015-0499-9] [PMID] [PMCID]
8. Toledo-Ibelles P, Mas-Oliva J. Antioxidants in the fight against atherosclerosis: is this a dead end? Curr Atheroscler Rep. 2018;20(7):36-. [DOI:10.1007/s11883-018-0737-7] [PMID] [PMCID]
9. Bhasker TV, Gowda NKS, Mondal S, et al. Boron influences immune and antioxidant responses by modulating hepatic superoxide dismutase activity under calcium deficit abiotic stress in Wistar rats. J Trace Element Med Biol. 2016;36:73-9. [DOI:10.1016/j.jtemb.2016.04.007] [PMID]
10. Cakir S, Eren M, Senturk M, Sarica ZS. The effect of boron on some biochemical parameters in experimental diabetic rats. Biol Trace Element Res. 2018;184(1):165-72. [DOI:10.1007/s12011-017-1182-0] [PMID]
11. Büyükgüzel E, Büyükgüzel K, Snela M, et al. Effect of boric acid on antioxidant enzyme activity, lipid peroxidation, and ultrastructure of midgut and fat body of Galleria mellonella. Cell Biol Toxicol. 2013;29(2):117-29. [DOI:10.1007/s10565-013-9240-7] [PMID] [PMCID]
12. Li G, Cheng T, Yu X. The impact of trace elements on osteoarthritis. Front Med. 2021;8. [DOI:10.3389/fmed.2021.771297] [PMID] [PMCID]
13. Weber KS, Ratjen I, Enderle J, Seidel U, Rimbach G, Lieb W. Plasma boron concentrations in the general population: a cross-sectional analysis of cardio-metabolic and dietary correlates. Europ J Nutr. 2022;61(3):1363-75. [DOI:10.1007/s00394-021-02730-w] [PMID] [PMCID]
14. Donoiu I, Militaru C, Obleagă O, et al. Effects of boron-containing compounds on cardiovascular disease risk factors - A review. J Trace Element Med Biol. 2018;50:47-56. [DOI:10.1016/j.jtemb.2018.06.003] [PMID]
15. Chekanov VS. Low frequency electrical impulses reduce atherosclerosis in cholesterol fed rabbits. Med Sci Monit. 2003;9(8):BR302-9.
16. Eren M, Guclu B, Uyanik F, N K. The effects of dietary boron supplementation on performance, carcass composition and serum lipids in Japanese quails. J Anim Vet Adv. 2006;5.
17. Donoiu I, Militaru C, Obleagă O, et al. Effects of boron-containing compounds on cardiovascular disease risk factors - A review. J Trace Element Med Biol. 2018;50:47-56. [DOI:10.1016/j.jtemb.2018.06.003] [PMID]
18. Ince S, Kucukkurt I, Cigerci IH, Fatih Fidan A, Eryavuz A. The effects of dietary boric acid and borax supplementation on lipid peroxidation, antioxidant activity, and DNA damage in rats. J Trace Element Med Biol. 2010;24(3):161-4. [DOI:10.1016/j.jtemb.2010.01.003] [PMID]
19. Naghii MR, Mofid M, Asgari AR, Hedayati M, Daneshpour MS. Comparative effects of daily and weekly boron supplementation on plasma steroid hormones and proinflammatory cytokines. J Trace Element Med Biol. 2011;25(1):54-8. [DOI:10.1016/j.jtemb.2010.10.001] [PMID]
20. Naghii MR, Samman S. The effect of boron on plasma testosterone and plasma lipids in rats. Nutr Res. 1997;17(3):523-31. [DOI:10.1016/S0271-5317(97)00017-1]
21. Pizzorno L. Nothing boring about boron. Integr Med (Encinitas). 2015;14(4):35-48.
22. Iorga A, Cunningham CM, Moazeni S, Ruffenach G, Umar S, Eghbali M. The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. Biol Sex Differ. 2017;8(1):33-. [DOI:10.1186/s13293-017-0152-8] [PMID] [PMCID]
23. Nielsen FH. Update on human health effects of boron. J Trace Element Med Biol. 2014;28(4):383-7. [DOI:10.1016/j.jtemb.2014.06.023] [PMID]
24. Bouchareb R, Katz M, Saadallah N, Sassi Y, Ali S, Lebeche D. Boron improves cardiac contractility and fibrotic remodeling following myocardial infarction injury. Sci Rep. 2020;10(1):17138. [DOI:10.1038/s41598-020-73864-w] [PMID] [PMCID]
25. Bhasker TV, Gowda NKS, Pal DT, et al. Influence of boron supplementation on performance, immunity and antioxidant status of lambs fed diets with or without adequate level of calcium. PLOS ONE. 2017;12(11):e0187203. [DOI:10.1371/journal.pone.0187203] [PMID] [PMCID]
26. Maksimenko AV, Vavaev AV. Antioxidant enzymes as potential targets in cardioprotection and treatment of cardiovascular diseases. Enzyme antioxidants: the next stage of pharmacological counterwork to the oxidative stress. Heart Int. 2012;7(1):e3-e. [DOI:10.4081/hi.2012.e3] [PMID] [PMCID]

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Advances in Medical and Biomedical Research

Designed & Developed by : Yektaweb